E. Tekgunduz Et Al. , "Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?," TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1, pp.30-34, 2016
Tekgunduz, E. Et Al. 2016. Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?. TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1 , 30-34.
Tekgunduz, E., Kaya, A. H., Bozdag, S. C., Kocubaba, E., Kayikci, O., Namdaroglu, S., ... Ugur, B.(2016). Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?. TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1, 30-34.
Tekgunduz, Emre Et Al. "Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?," TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1, 30-34, 2016
Tekgunduz, Emre Et Al. "Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?." TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1, pp.30-34, 2016
Tekgunduz, E. Et Al. (2016) . "Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?." TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1, pp.30-34.
@article{article, author={Emre Tekgunduz Et Al. }, title={Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?}, journal={TRANSFUSION AND APHERESIS SCIENCE}, year=2016, pages={30-34} }